Apollo Hospitals Enterprise reported a 32% rise in Q2 FY27 profit to ₹630 crore, supported by a 23% increase in revenue. The company also announced a five-year plan to add 5,800 beds to its network. Following these results, the stock rose nearly 2% as investors assessed the expansion strategy and upcoming management changes.
Apollo Hospitals Enterprise reported strong financial performance for the second quarter of the fiscal year 2027, with net profit rising 32% year-on-year to ₹630 crore. Revenue from operations also grew by 23%, reaching ₹7,615 crore. Following the announcement, the company's shares gained 1.89% to close at ₹8,599.50 on November 4, 2026, reflecting investor confidence in the company's growth trajectory.
Strategic Capacity Expansion
The company is embarking on a significant expansion drive, aiming to add 5,800 beds to its hospital network over the next five years. This initiative is focused on capturing the growing demand for high-end medical services. A key project in this pipeline is a 470-bed hospital in Gurugram, which is scheduled to begin operations in the third quarter of the 2027 fiscal year. This expansion is supported by improvements in current operations, as hospital occupancy levels climbed to 73% in the September quarter, up from 69% in the same period last year.
Management and Corporate Changes
While the company pushes forward with its expansion, it is also undergoing a management transition. Dr. Madhu Sasidhar, the President and CEO of the Hospitals Division, will step down from his position effective November 14, 2026. Additionally, the company is refining its portfolio; it completed the divestment of its stakes in Apollo Specialty Hospitals and Apollo Fertility Centre to Kids Clinic India Limited (Cloudnine) on November 3, 2026. These moves suggest a focus on streamlining operations while prioritizing core hospital growth.
Risks and Future Monitorables
Investors may keep a close watch on the execution of the new projects. A primary risk with rapid hospital expansion is the impact of startup costs, where new facilities often report initial losses before reaching profitable occupancy levels. These “gestational losses” can weigh on overall profit margins in the short term. Furthermore, the healthcare sector remains sensitive to regulatory changes, such as adjustments to medical procedure tariffs or pharmaceutical trade margins, which can affect profitability. Success for the company will depend on its ability to scale these new hospitals efficiently without letting operating costs outpace revenue growth.